Myelodysplastic Syndrome Treatment in Faridabad

Myelodysplastic Syndrome (MDS) is a group of bone marrow disorders in which the body struggles to produce healthy blood cells. It can lead to low red blood cell, white blood cell or platelet counts, increasing the risk of fatigue, infections, anaemia and bleeding. MDS is considered a myeloid blood cancer, although its severity and progression can vary significantly from one person to another.

Receiving an MDS diagnosis can raise many questions for patients and their families. Understanding the condition, identifying its risk category and exploring appropriate treatment options are important steps towards informed medical care.

What Is Myelodysplastic Syndrome (MDS)?

Myelodysplastic Syndrome refers to a group of disorders that affect the bone marrow, where blood cells are produced. In MDS, blood-forming cells may develop abnormally and fail to mature into healthy, functional blood cells.

As a result, patients may develop low blood counts, even when the bone marrow is producing blood cells. The condition can affect daily activities and overall well-being, depending on the severity of the blood count abnormalities.

Some forms of MDS progress slowly, while others carry a higher risk of developing into acute myeloid leukaemia (AML). An accurate diagnosis and risk assessment help the treating specialist determine the most appropriate management approach.

Common Symptoms of Myelodysplastic Syndrome

The symptoms of Myelodysplastic Syndrome depend on which blood cells are affected and how low their levels become. Some patients may have no noticeable symptoms initially and discover abnormal blood counts during routine blood tests.

Common symptoms may include:

Persistent fatigue and weakness: Often associated with anaemia and reduced oxygen delivery to body tissues.
Shortness of breath: May occur during everyday activities when red blood cell levels are low.
Frequent infections: Low levels of healthy white blood cells can make it harder for the body to fight infections.
Easy bruising or bleeding: Low platelet counts may cause unusual bruising, nosebleeds or bleeding gums.
Pale skin and dizziness: These may occur due to anaemia.
Reduced stamina: Patients may find it harder to manage their usual daily activities.

These symptoms can also occur in other conditions. A medical evaluation and appropriate blood tests are necessary to identify the underlying cause.

Myelodysplastic Syndrome Treatment Options

The treatment of Myelodysplastic Syndrome depends on the disease subtype, risk category, blood counts, symptoms, genetic findings, age and overall health. The main goals may include improving blood counts, reducing complications, controlling disease progression and improving quality of life.

Supportive Care and Blood Transfusions
Patients with significant anaemia or low blood counts may need supportive care. Depending on the clinical situation, this may include red blood cell or platelet transfusions, infection management and other measures to address complications.
Growth Factors and Medicines for Anaemia
Certain medicines, including erythropoiesis-stimulating agents, may help improve red blood cell production in selected patients. The choice depends on factors such as the severity of anaemia and other clinical findings.
Disease-Modifying Treatment
Medicines such as azacitidine or decitabine may be considered for appropriate patients, particularly in higher-risk MDS. Other treatments may be recommended according to specific disease characteristics and genetic findings.
Targeted Treatment for Selected MDS Subtypes
Some patients may benefit from subtype-specific treatment. For example, lenalidomide may be considered for selected patients with MDS associated with an isolated deletion of chromosome 5q. Treatment decisions require appropriate diagnostic and genetic evaluation.
Stem Cell Transplantation
Allogeneic stem cell transplantation is the only established potentially curative treatment for MDS. However, it is not suitable for everyone. Eligibility depends on disease risk, overall health, age, donor availability and the potential benefits and complications of transplantation. The treatment plan should be personalised after a thorough assessment and discussion between the patient and the treating specialist.

How Is Myelodysplastic Syndrome Diagnosed?

An accurate diagnosis helps determine the type of MDS, assess disease risk and guide treatment decisions. The diagnostic process may include the following investigations.